DCVC H1 HA mRNA vaccine
- Generic Name
- DCVC H1 HA mRNA vaccine
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
Phase 1
Recruiting
- Conditions
- Influenza
- Interventions
- Biological: Quadrivalent Recombinant Seasonal Influenza VaccineOther: Sodium Chloride, 0.9%
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 50
- Registration Number
- NCT05945485
- Locations
- 🇺🇸
University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath